Food and Drug Administration v American College of Obstetricians and Gynaecologists 592 U.S.__ (2021)
A majority of the Supreme Court of the United States stayed an order by the District Court which suspended the requirement that people attend a hospital or clinic in-person in order to obtain mifepristone, a prescription drug used for medical abortions.
In July 2020, the District Court found that the in-person requirement posed an “undue burden” on people seeking an abortion in light of the COVID-19 pandemic. The Supreme Court’s decision reinstates the Food and Drug Administration’s requirement that patients attend a hospital, clinic, or medical office to pick up mifepristone and sign a disclosure form.
Read More